Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 12

Showing 12 citing articles:

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Current status and trends in small nucleic acid drug development: Leading the future
Yuxi Miao, Chen Fu, Zhaojin Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3802-3817
Open Access | Times Cited: 15
The Growing Class of Novel RNAi Therapeutics
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 13
Oral Piwi‐Interacting RNA Delivery Mediated by Green Tea‐Derived Exosome‐Like Nanovesicles for the Treatment of Aortic Dissection
Yan Liu, Hongzhao Qi, Jinbao Zong, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 8
Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents
Gavin M. Traber, Colleen Yi, Neelu Batra, et al.
RNA (2024), pp. rna.079904.123-rna.079904.123
Open Access | Times Cited: 6
piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer
Honglei Qin, Yang Han, Jianqi Li, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries
Huang‐Ping Yu, Fu-Chao Liu, Yu-Kuo Chung, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4411-4437
Open Access | Times Cited: 2
Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
Erika L. Hellenbart, Heather J. Ipema, Mary Rodriguez Ziccardi, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024)
Open Access | Times Cited: 2
Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis
Marcella Steffani, Yana Geng, Utpal B. Pajvani, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 1
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice
Siqian Ma, Boyan Liu, Hong Du, et al.
Journal of Thrombosis and Thrombolysis (2024) Vol. 57, Iss. 8, pp. 1349-1362
Open Access
Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures
Frank Yiyang Mao, Mei‐Juan Tu, Gavin M. Traber, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 6, pp. 55-55
Open Access
Nanocarrier‐Mediated RNA Delivery Platform as a Frontier Strategy for Hepatic Disease Treatment: Challenges and Opportunities
Jinhui Fan, Zhicheng Xiao, Yafen Dong, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 4
Closed Access
Page 1

Scroll to top